Gosebruch Henry O insider trades
Gosebruch Henry O has filed 12 Form 4s with the SEC that we hold, for AbbVie Inc. (ABBV) (EVP, Chief Strategy Officer), SLRN (Director), Neumora Therapeutics, Inc. (NMRA) (President & CEO, Director) and APTX (Director), among 5 companies in all. Across all of them we count 2 purchases worth $1.1M and 8 sales worth $18.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 83,960 shares of AbbVie Inc. worth $13.0M, dated 2022-05-16. The first filing on our record is dated 2021-09-10 and the latest 2026-08-27.
AbbVie Inc. (ABBV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-01 | S, sale reported on Form 4 | 5,596 | $825.6K | 2022-03-01 |
| 2022-03-01 | S, sale reported on Form 4 | 8,303 | $1.2M | 2022-03-01 |
| 2022-03-01 | S, sale reported on Form 4 | 1,101 | $164.2K | 2022-03-01 |
| 2022-03-01 | S, sale reported on Form 4 | 15,733 | $2.3M | 2022-05-20 |
| 2022-03-01 | S, sale reported on Form 4 | 5,167 | $762.6K | 2022-05-20 |
| 2022-03-01 | S, sale reported on Form 4 | 100 | $14.9K | 2022-05-20 |
| 2022-03-01 | S, sale reported on Form 4 | 4,000 | $594.8K | 2022-05-20 |
| 2022-05-16 | S, sale reported on Form 4 | 83,960 | $13.0M | 2022-05-20 |
SLRN
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-05-09 | P, purchase reported on Form 4 | 50,000 | $900.0K | 2023-05-11 |
Neumora Therapeutics, Inc. (NMRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-19 | P, purchase reported on Form 4 | 15,000 | $189.3K | 2023-09-19 |
APTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Ani Pharmaceuticals INC (ANIP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1659625) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms